Core Scientific, Inc.
CORZ
Category
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | -3.24 | 18.67% |
| 2024 | -2.73 | -48.44% |
| 2023 | -5.30 | 870.95% |
| 2022 | -0.55 | -103.62% |
| 2021 | 15.07 | -223.99% |
| 2020 | -12.15 | -2.33% |
| 2019 | -12.44 | 0.00% |
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 29.65 | -1,015.16% |
US
|
|
| 159.50 | -5,023.14% |
US
|
|
| 20.15 | -721.82% |
US
|
|
| 815.30 | -25,265.27% |
US
|
|
| 7.08K | -218,696.90% |
US
|
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.